Cancer, Anne Marie, Duracell Clinic discussed on The Naked Scientists

Automatic TRANSCRIPT

Entire clinical team including the pathologist radiologists surgeons and nurses them meet to discuss each patient and the best way to manage their case. It depends on the biopsy type because if it is transparently biopsy we take more samples so that take long to expand if it is translated told standard by up say it usually take ten days and then be discussed the case in multi disciplinary team meeting. And we see the patient and gave that assaults and stage. What do you say to the patients? Or what information can you impart to them? And what's the next step so in duracell clinic? We will have the information about the biopsy yourself better. It is a cancer or note if it is a cancer what grade of the cancer and we would have discussed what treatment option is available for patients so when we see the patient be will discuss the findings of the biopsy say advance stories a locally advanced or early prostate cancer and we discussed the treatment options with the patient. We can now worker with quite good accuracy. Where the likely prognosis meeting to see the outcome is with or without treatment. And that's what we use together with the patient to work out what to do next. The first thing to know is that there is absolutely no evidence that rushing through a diagnosis of prostate. Cancer has any impact and survival. So it doesn't really matter how long it takes. The key thing is that he's done well in general terms from the minute somebody presents to say the hospital for investigations to get Anne Marie. Scan to be seen to have a biopsy and get a diagnosis. We try to do that within two or three weeks and then we can make decisions about what to do next. Some people listening to this may be wondering why it is that we have screening programs for certain diseases. But we don't have one for this given that you've said that eighty percent of men aged eighty may well have prostate cancer which argues perhaps would be worth looking for. It's it's therefore very common condition. Why is there no screening program for prostate cancer so the problem screening in prostate cancer is not the fact that it isn't save lives because he does the problem as that he picks up a lot of disease which is treatment and that over diagnosis can also lead over treatment because of poor understanding of the natural history of disease sort of instinct treat rather than monitor and if you look at the statistics as well is very hard to justify so for example in prostate cancer terms the lifetime risk of developing prostate? Cancer is nearly ten times risk of dying of it. You have to find an awful lot of men to save a single life but problem with screening is that its tended to rely on a single test at a single point in time and the test is in good. Psa Like I said is a nice test but it's just not good enough and so a lot of our work. A lot of work of others is actually trying to do two things. Define what is the right time point to pick it up and secondly trying to get a better test to pick it up. Are you having any luck? Yes there are actually a number of tests out there which already better than the pse. The problem is that the cost more as well. We are very interested in actually binding better tests with a much more evolving way of looking at this because the way we see it is that each man's risk changes with time and how put together as what we are exploring at the moment but. I do think we have the tools to be able to better detect Kansas which are going to spread for example and actually intervene enough and would that translate into a saving? And that's exactly what the Holy Grail is. Because in the end of the day screening low early detection for cancer actually has converse side which is not picking up things that you don't want to pick up and that in itself is a goal which I think is worth doing because if you can reduce the number of people you're going to be looking for something that means you can get your resources redirected to finding the ones which are important. Most of the time we're so fixated on finding and more and more cancers that's what we WANNA do. We forget about the fact that there's a lot of people who are investigated who turn out not to have chances And that is actually a big burden for the health economy for the individual and ultimately if you do diagnose something which too early you you do. Condemn someone to be monitored for something which didn't know about. It's a little bit lake saying if we started do genetic testing birth everyone what it tells us a potential. You might get something rather than you will get something and then you're going to end up stressed body for all your life and.

Coming up next